Harrisvaccines Inc., Ames, Iowa. – Kurt Kamrud has joined the company as Vice President for Research and Chief Scientific Officer. He will oversee vaccine development and be responsible for interactions with the USDA. Kamrud was previously with AlphaVax, Inc., Research Triangle Park, North Carolina.
Dr. Kamrud is an expert in the field of infectious diseases. After completing his Doctorate in microbiology, focusing on the use of alphavirus vectors to examine insect/virus interactions, he conducted research at the United States Army Medical Research Institute for Infectious Diseases (USAMRIID) developing alphavirus replicon-based vaccines. Prior to joining Harrisvaccines in June of 2010, Dr. Kamrud served as the Director of Discovery at AlphaVax, Inc., the commercial developer of the alphavirus replicon vaccine system used at Harrisvaccines. Dr. Kamrud has been granted 4 international patents pertaining to the alphavirus replicon system.
For More Information Please Contact:
Chief Marketing Officer